Phase I pharmacokinetic trial of asunaprevir/daclatasvir/BMS 791325 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 13 Apr 2014
Price : $35 *
At a glance
- Drugs Asunaprevir/becabluvir/daclatasvir (Primary) ; Asunaprevir; Beclabuvir; Daclatasvir
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 03 Apr 2014 New trial record
- 24 Mar 2014 Results will be presented at The International Liver Congress, the 49th annual meeting of the European Association for the Study of the Liver (EASL) according to a Bristol-Myers Squibb media release.